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Ultrasound-guided carpal tunnel release(USCTR) was performed on 14 patients (18 wrists) using  
dynamic expansion of the transverse safe zone.  Our patient population included able bodied and  
those with impairments.  The first 8 cases/12 wrists were performed in an operating room, the  
remainder in an outpatient setting.  No complications occurred, and all patients were able to  
immediately resume use of their hands without therapy.  Improvements in QuickDASH and  
Boston Carpal Tunnel Questionnaire (BCTQ) at 3 months were comparable to results reported  
with mini-open and endoscopic release.  Our series show USCTR can be safely and effectively  
performed in an outpatient setting.     
  
 INTRODUCTION  
  
Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy  
and has an incidence of 3.5-6.2%, leading to 450,000 surgical releases annually at a total cost of  
over 2 billion dollars. 
1-3
 Greater than 90% of patients report clinical improvement following  
release. 
4-6
  Although initially performed via a large (3-5 cm), palmar incision, carpal tunnel  
release (CTR) techniques have continually evolved to reduce surgical trauma, with the goal of  
improving cosmesis, reducing post-operative pain, and promoting faster recovery. 
7
  Currently  
available CTR techniques include mini-open CTR (mOCTR) via a single, 1-3 cm palmar  
incision, endoscopic CTR (ECTR) via one (wrist) or two (wrist and palm) 1-2 cm incisions, and  
ultrasound-guided CTR (USCTR) via a single < 1 cm wrist or palmar incision. 
8-10
      
Regardless of technique, the primary goal of CTR is to transect the transverse carpal  
ligament (TCL) while avoiding injury to nearby neurovascular structures. 
11
  Although ECTR  
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may promote a faster recovery compared to mOCTR, concerns have been raised regarding the  
potential for increased complications due to limited visualization of surrounding structures  
during TCL transection.
10-12
 USCTR techniques combine a single small incision with direct US  
visualization of at-risk structures, such as the median nerve and its thenar motor branch/recurrent  
motor branch, ulnar vessels, and superficial palmar arterial arch.
13-20
  To date, over 620 cases of  
USCTR have been reported in the peer-reviewed literature with a >98% clinical success rate and  
no documented neurovascular injuries.
7,21-26
  Furthermore, a recently published, single surgeon,  
prospective randomized clinical trial comparing mOCTR to USCTR reported that patients  
treated with USCTR experienced significantly faster functional recovery, pain reduction, and  
pain medication discontinuation. 7  
To transect the TCL, ECTR techniques and most USCTR techniques place the surgical  
device within the transverse safe zone (TSZ), a region bordered radially by the median nerve and  
ulnarly by the hook of the hamate or ulnar vessels, whichever lies more radially.
7,21,23,24,27,28
  The  
TSZ width can range from 4-8 mm but exhibits significant inter-individual variability and in  
some individuals can be < 3mm, or even 0mm.
21
 Transection of the TCL through a small skin  
incision, while at the same time establishing an acceptable TSZ, is a technical challenge with  
both ECTR and USCTR.  During ECTR, both the minimal incision size and the maximally  
available TSZ are determined by the size of the introducer sheath and endoscopic cannula. In  
contrast, previously described USCTR techniques require only a very small (< 1 cm) skin  
incision, but can challenge the operator to establish and maintain an acceptable TSZ.
7,21,23,24,27
    
A single use, disposable device (SX-One MicroKnife, Sonex Health LLC, Rochester,  
MN) has recently become commercially available. The device allows the user to establish and  
maintain an acceptable TSZ, via the use of expandable protective balloons. The device is inserted  
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through a single <5 mm distal forearm skin incision and into the carpal tunnel TSZ, under direct  
USG. The protective balloons allow for a consistent TSZ of approximately 8 mm while a  
retractable microknife cuts the TCL 4-6 mm radial to the hook of the hamate.  A recently  
performed cadaveric investigation using the same device to perform USCTR in 34 unembalmed,  
cadaveric specimens documented a 100% rate of TCL release and no neurovascular injuries as  
assessed by independent observers.
29
  
The primary purpose of this manuscript is to document our initial intermediate-term (3  
month) clinical results performing USCTR using enhanced transverse safe zone control in a  
consecutive group of 14 patients (18 wrists).  We hypothesized that USCTR using enhanced  
transverse safe zone control can be performed safely and effectively in an office or procedure- 
room setting and will allow patients to rapidly recover, including those patients dependent on  
their upper limbs for ambulation.  
    
METHODS  
 A total of 16 patients (22 wrists), ages 62-90 (mean 64 years), with carpal tunnel  
syndrome were recruited for USCTR from the Physical Medicine and Rehabilitation clinic at the  
lead author’s institution.  Two patients/4 wrists were lost to follow-up 4 weeks post-release and  
are therefore not included in this report.  As of their last follow-up point 4 weeks after release  
these two patients had reported no complications and were recovering uneventfully.  Therefore,  
14 patients/18 wrists were followed for 12 weeks after release.  Patients included able-bodied  
individuals and those with functional impairments, specifically one patient with post-polio  
syndrome who ambulated with forearm crutches, one with multiple sclerosis who did not use  
assistive devices, and two with paraplegia who ambulated with a manual wheelchair.   Selection  
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criteria included history and examination consistent with CTS, electrodiagnostic testing  
confirming median neuropathy at the wrist and persistent, functionally limiting symptoms  
for > 3 months despite non-operative treatment including activity modification and/or splinting  
or corticosteroid injections.  All procedures were performed by a single fellowship-trained  
physiatrist (TH) with more than 8 years of clinical experience in diagnostic and interventional  
musculoskeletal ultrasound (US).    The initial 8 cases (12 wrists, 4 bilateral and 4 unilateral)  
were performed in the Operating Room (OR) in conjunction with a fellowship-trained  
Neurosurgeon (LY) (not scrubbed in but present for supervision). While in the OR, all standard  
protocols were followed with respect to sterile preparation and anesthesia, including the use of  
conscious sedation with appropriate monitoring.  The subsequent 8 cases (10 wrists, 2 bilateral  
and 6 unilateral) were performed in an outpatient setting solely by the primary author following  
standard protocols for outpatient local anesthesia (i.e. no conscious sedation). This manuscript  
presents the prospective 3-month results of a 12-month study investigating the safety and clinical  
outcomes of the procedure. All patients were followed using validated outcome measures (the  
Boston Carpal Tunnel Questionnaire (BCTQ) and Quick form of the Disabilities of the Arm,  
Shoulder and Hand index (QDASH).  The pre-procedure results were collected on the day of the  
release.  One and three-month post- procedure data were collected via mailed questionnaires or  
follow up phone calls by office staff.  One set of scores was collected at each interval regardless  
if the patient underwent unilateral or bilateral releases.        
 The BCTQ and QDASH are measures of pain and function commonly used in the  
evaluation of interventions related to CTS.
30
  The BCTQ has a calculated symptom score  
(BCTQ-SS) and a functional status score (BCTQ-F) which range 1-5.  The QDASH score ranges  
from 0 -100.   Higher scores for both instruments indicate worse symptoms and poorer functional  
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status. In addition, two non-validated global outcome measures were utilized at 3-month follow- 
up, assessing if symptoms improved (yes/no) and how satisfied patients were with the results of  
the procedure (5 point ordinal scale: 1 = very dissatisfied, 2 = dissatisfied, 3 = neither satisfied  
nor dissatisfied, 4 = satisfied, 5 = very satisfied).   This study was performed in accordance with  
the Declaration of Helsinki. This human study was approved by Institutional Review Board of  
the University of Michigan Medical School (IRBMED) - approval: HUM00127628. All adult  
participants provided written informed consent to participate in this study.    
  Prior to USCTR all wrists were evaluated using high frequency transducers on US  
equipment available in the Department of Physical Medicine and Rehabilitation (15-6 MHz  
linear array transducer on a Sonosite X-Porte, Fujifilm Sonosite, Bothell, WA, or a 18-5 MHz  
linear array Philips Affinity, Philips Corporation, Bothell WA).  This evaluation utilized  
standardized protocols including identification of the thenar motor/recurrent motor and  
palmar cutaneous branches of the median nerve, and any communicating branches  
between the median and ulnar common digital nerves (so called Berrettini branches)17,31 .   
The purpose of this evaluation was not only to assess the median nerve but also to identify  
contraindications to proceeding with USCTR, which included: (a) Inability to adequately  
visualize at-risk structures including the thenar motor branch/recurrent motor branch of the  
median nerve, palmar cutaneous branch of the median nerve, ulnar vessels, superficial palmar  
arterial arch, and median and ulnar palmar digital nerves, (b) Distorted or variant anatomy that  
would preclude establishment of a safe TSZ, or (c) Presence of mass lesion or other process that  
requires treatment beyond transection of the TCL.  No patients were excluded based on US  
findings.    
Procedure Description  
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 All USCTR procedures were performed by the primary author using the MicroKnife  
device in accordance to the manufacturer’s instructions, the high frequency linear array  
transducers previously described, and in accordance to manufacturer’s instructions. All patients  
received an USG local anesthetic injection of approximately 8 mL of 1% lidocaine without  
epinephrine via a 25-gauge 50 mm needle.  Care was taken to generously infiltrate the planned  
incision site at the proximal wrist crease (Figure 1) and the palmar fascia superficial to the TCL.   
This needle was then withdrawn, and a second 25-gauge 50 mm needle was used to hydro- 
dissect the median nerve away from the flexor tendons and TCL using 10 ml of sterile 0.9%  
normal saline under direct ultrasound guidance (USG). This allowed for better delineation of the  
boundaries of the TCL. Then under ultrasound guidance, a #15 blade scalpel was used to make  
vertical stab incision through the pre-anesthetized skin wheal down to and through the  
antebrachial fascia.  Following this, USG was used to accurately place the device into the carpal  
tunnel, within the TSZ and position the tip just distal to the distal aspect of the TCL. The tip of  
the device was positioned superficial to the mid-palmar fat pad and proximal and superficial to  
the superficial palmar arterial arch, approximately 1cm distal to the hook of the hamate.   
Evaluation of the device’s position in and out of plane relative to the transducer performed to  
ensure proper positioning of the device immediately deep to the TCL and radial to the pisiform  
and hamate. ( Figure 2A-C) The handle on the device was then depressed and locked, filling the  
balloons to expand and maintain the TSZ. (Figure 2D and supplementary video 1) The device  
was manipulated slightly ulnarly or radially to optimally position the cutting knife (once  
activated) away from the path of the median nerve and the ulnar neurovascular structures.  Once  
appropriate positioning in the TSZ was again sonographically confirmed, the knife was deployed  
and translated in a distal-to-proximal direction under direct USG to transect the TCL (Figure 3A- 
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B and supplementary video 2).  The knife was then advanced back to its distal location, the  
regional anatomy re-checked using ultrasound, and a second pass was completed with the knife  
to ensure complete TCL release.  Following complete release. the knife was recessed into its  
protected position and the protective balloons were deflated.  The position of the device was  
evaluated via US to confirm a now superficial location relative to the TCL and osseous  
boundaries of the carpal tunnel. The TCL was then probed with the device through the area of  
transection to ensure no remaining intact fibers persisted (Figure 4 and Supplementary video 3).   
Probing confirmed complete TCL transection in all cases, and no additional passes were  
required.   The device was then removed from the incision, excess fluid and blood was expressed  
through the wound followed by adhesive bandages (Steri-Strips) or 4-0 nylon suture closure.  
(Figure 5) A sterile gauze pad and occlusive dressing were applied.  The average total time of the  
procedure and balloon inflation times were 7 minutes and 2 minutes respectively and the incision  
length was < 5mm.   
Post-procedure neurologic and physical exam were performed to ensure no neurologic or tendon  
injuries had occurred.  All patients were discharged home under their own power at the same  
level of pre-procedure function.  No activity limitations were imposed and none of the patients  
required a therapy referral post release. One patient that used bilateral forearm crutches and two  
that used manual wheelchairs were able to immediately resume the use of these ambulatory aides  
after release.     
  
Results   
All 16 patients/22 wrists were evaluated in person by the operator one-week post-procedure.   
There were no complications and all wounds had healed by the first post-operative visit. All  
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patients had reported full use of their hands since the day of the procedure.  As previously stated,  
2 patients/4 wrists were lost to follow-up thereafter and were not included in the formal data  
analysis.  Patients were then mailed the BCTQ and QDASH forms and the two patient oriented  
outcome measures to collect the 3-month interval data.  Those that did not respond by mail were  
contacted by office staff and completed the surveys over the phone.  At one and three months,  
the average BCTQ-SS score improved from 2.96 pre-release to 1.75 and 1.54 respectively  
(difference 1.42), and the average BCTQ-F status improved from 2.64 pre-release to 1.75 at one  
and 3 months (difference 0.89). (Table 1)  The average QDASH scores improved from 45 to 19  
(one month) and 18 (3 month) (difference 27). (Table 2)  All patients reported improvements in  
symptoms and the average global satisfaction rating was 4. Importantly, all the patients with  
impairments retained their pre-procedure level of independence throughout this initial follow-up  
period.    
 While not formally collected, we did solicit feedback from patients regarding their  
experience with USCTR.  In general, patients described minimal post-operative pain. Most  
patients reported adequate pain relief with ice, limb elevation and over the counter  
analgesic/anti-inflammatory medications.   Additionally, patients who received USCTR in the  
office setting using only local anesthesia generally reported little discomfort throughout the  
procedure.  In this setting many patients also volunteered their satisfaction with the convenience  
of the procedure with regard to having the procedure done in the outpatient setting, the ease of  
scheduling, the lack of need to modify medications or dietary intake on the day of the procedure,  
and the ability to immediately resume use of affected limb.   
Discussion  
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 The most important finding of the current report is that USCTR using enhanced  
transverse safe zone control can be safely implemented in both the OR and outpatient settings  
with excellent intermediate-term results in a diverse patient population.  In our initial group of 14  
patients/18 wrists there were no complications and clinical improvement was similar to that  
previously reported for mOCTR, ECTR, and USCTR.
5,7
  More specifically, the 3-month  
improvements in BCTQ-SS and BCTQ-F scores in our cohort were 1.42 and 0.89, respectively,  
which exceed the minimally clinically important differences (MCIDs) of 1.14 and 0.74  
previously reported by Kim et al. following limited open carpal tunnel release.
32
  Similarly, it has  
also been reported by Clement et al. that patient satisfaction 3-months following OCTR highly  
correlated with a post-release QDASH of ≤ 34 or a post-CTR reduction of  >20 points. 
30
   In the  
cohort presented in this manuscript, the average 3-month QDASH was 18 and average reduction  
was 27, reflecting high patient satisfaction.   
 Currently, most CTRs are performed using the mOCTR approach with predictably good  
results and a low complication rate.
11,12
  However, the palmar incisions used for mOCTR may  
slow recovery and necessitate significant alterations in hand and upper limb function during  
recovery.
7,11,12
 This can lead to increased time away from work or a short stay at a skilled nursing  
facility for those dependent on use of their upper limbs for transferring and ambulation. Indeed, 3  
patients presented in this study were crutch or wheelchair ambulators and were able to transfer  
and ambulate immediately post-procedure. Smaller incision sizes and reduced procedural trauma  
appear to promote faster recovery.  Studies have demonstrated that patients treated with ECTR or  
USCTR recover faster and may have less post-procedural pain compared to those treated with  
mOCTR, presumably in part due to reduced surgical trauma.
12
  These observations have resulted  
in the historical trend of using smaller palmar incisions for OCTR (i.e. mOCTR). However, the  
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smaller palmar incisions used during mOCTR may make the procedure more technically  
challenging and still require temporary avoidance of palmar pressure. Although ECTR appears to  
promote a faster recovery and may allow immediate palmar “weightbearing” (in the single  
incision technique), ECTR is more difficult to perform outside of the operating room setting.   
ECTR is also more expensive than mOCTR and has been associated with a higher risk of  
neuropraxia, presumably due to the relatively large size of the cannula and lack of complete  
visualization of surrounding structures.
11,33
   USCTR provides the advantages of ECTR while  
allowing the operator to perform the procedure in the office based setting using real-time  
visualization of all relevant structures. Innovations in image-guided procedures (trigger digit  
release, tenotomies, fasciotomies and neurolysis) have advanced in-parallel with improved US  
technology, accessibility, and skilled operators.
34,35
  USCTR has been evolving in the past two  
decades but has primarily relied on instruments borrowed or repurposed from other procedures,  
for example, the hook knife.
23,36,37
  USCTR using enhanced transverse safe zone control is the  
latest advancement in this field and is distinguished by providing the user the ability to access the  
carpal tunnel via a small forearm incision, control the TSZ via inflatable balloons, and efficiently  
cut the TCL in a variety of practice settings.    
 Study strengths include the prospective collection of data using validated patient reported  
outcome measures, a high follow-up rate (>87%) and inclusion of patients with physical  
impairments dependent on upper limb function for mobility.  Nonetheless, we acknowledge  
several limitations of the current report.  First, neither the patient, nor the assessors were blinded  
to the intervention and there was no comparative or control group.  However, the primary  
purpose of this investigation was to report our initial experience using USCTR with enhanced  
transverse safe zone control in a clinically relevant setting, including a diverse patient population  
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and the use of local anesthesia only.  Future studies may include direct comparisons with  
alternative CTR techniques. Second, we are reporting our intermediate results at 3-month post- 
procedure.  While this follow-up period may be short, it is sufficient to document the safety of  
USCTR with enhanced transverse safe zone control as used to treat our patients.  Furthermore,  
since 100% of patients returned to normal activities within the follow-up period, this duration of  
time was sufficient to document the efficacy of the treatment, as reflected in previous studies.
7,22
   
Nonetheless, we will continue to follow our patients for 12-months as previously stated.  Third,  
our sample size is relatively small and include patients treated by a single operator.  Future  
studies should include larger sample sizes and possibly combine experiences from multiple  
users.   
 Our initial experience with USCTR using enhanced transverse safe zone control  
demonstrates that this procedure can be safely and effectively performed in an outpatient setting  
by physicians who have expertise in advanced ultrasound guided procedures.   Specific  
advantages of USCTR as implemented in our practice include but are not limited to: (1)  
increased patient convenience of office/procedure room setting using only local anesthesia,  
freeing up ORs for more complex cases (2) use of small, forearm incision with the ability to  
immediately use the upper limbs, (3) improved user and patient confidence given the ability to  
directly visualize all carpal tunnel structures using US and control the TSZ via the use of the  
inflatable balloons, and (4) reduced need for support personnel following transition to the clinic,  
accompanied by potential cost savings.  The convenience of the office/procedure room and  
ability to immediately weight bear on the upper limbs are particularly advantageous to patients  
with functional limitations, as was the case for 3 of our patients.  Further assessment of USCTR  
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using enhanced transverse safe zone control is justified and should include the assessment of  
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Table 1.  Boston Carpal Tunnel Questionnaire Mean Scores  
 Symptom Severity (range) Functional Status (range) 
Pre Release 2.96 (1.82 – 4.18) 2.64 (1.12 – 3.5) 
1 Month Post 1.75 (1 - 3.36) 1.75 (1 – 3.12) 
3 Months Post 1.54 (1.09 – 2.54) 1.75 (1 – 3.12) 
3 Month Change 1.42 0.89 
MCID at 3 Months 
36
 1.14 0.74 
   N = 14  
   MCID = minimal clinically important difference   
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Table 2.  QDASH Mean Scores  
  (range) 
Pre-Release 45 (16 – 72) 
1 Month Post 19 (0 – 55) 
3 Months Post 18 (0 – 39) 
3 Month Change 27  
N = 14 
MCID score 34 or change in score > 20 
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Figure Legends  
  
Figure 1.   Pre-procedural Anatomic Markings and Skin Incision  
Picture of incision placement along the distal forearm and device direction of insertion (arrow).   
Skin markings highlight the anatomic landmarks to assist during procedure.  Blue line represents  
place for incision.  Black dashed and solid red line marks location of the median nerve and ulnar  
artery respectively. a- superficial palmar arch; H- hook of hamate; P- pisiform, Mn- median  
nerve, U- ulnar nerve, S-scaphoid; T- Trapezium  
  
Figure 2.  Placement of Device and Balloon Inflation  
A) External intra-operative photo of device placement.  The device is initially inserted vertically  
until penetrating the antebrachial fascia, after which is advanced distally oblique-parallel to the  
forearm. B) In-plane view of the device within the carpal tunnel with proximal (PROX) to the  
left of the image. The device is placed ~1 cm distal to the TCL (arrows) to ensure complete  
release. C) Out-of-plane view of the device (open arrow) within the transverse safe zone (dotted  
double arrow) at the level of the distal carpal tunnel (solid arrows). The protective balloons  
(curved arrows) are deflated as demonstrated in the insert.  The TSZ in this patient is bordered  
by the ulnar artery, which encroaches in the tunnel. Therefore, the ULN side of arrow spans from  
the median nerve (dotted ellipse) to the ulnar artery (a) and not the hook of the hamate (H). D)  
Out-of plane view of the device with protective balloons (curved arrows) inflated as  
demonstrated in the insert. Note expansion of the TSZ (dotted double arrow) and the radial  
displacement of the median nerve (dotted ellipse).  FT- flexor tendons; Solid ellipse- ulnar nerve;  
ThM- Thenar muscles; ULN- ulnar  
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Figure 3.   Ultrasound-Guided Release of the Transverse Carpal Ligament  
A) External picture of the device with protective balloons inflated and the retrograde cutting  
knife (open arrow) deployed.  B) Correlative US in-plane view of the device with distal (DIST)  
to the right of the knife (open arrow) cutting the TCL (solid arrows)  
  
Figure 4.  Ultrasound Confirmation of Complete Release of the Transverse Carpal  
Ligament  
Out of plane view of device (open arrow), with the protective balloons (curved arrows) deflated,  
showing the device superficial to the boundaries of the transected TCL (solid arrows).    
a- ulnar artery; FCR- flexor carpi radialis - FT- flexor tendons; Rad- radial; S- scaphoid; Solid  
ellipse- ulnar nerve; ThM- Thenar muscles; ULN- ulnar  
  
Figure 5.  Post-procedure wound closure  
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Supplementary Video Legend  
  
Supplementary Video 1: Balloon Inflation:   
Out-of plane US image of inflation of the protective balloons (curved arrows) within the TSZ  
(dotted double arrow) with ulnar (ULN) to the right of the image. The TSZ in this patient is  
bordered by the ulnar artery, which encroaches in the tunnel. Therefore, the ULN side of arrow  
spans from the median nerve (dotted ellipse) to the ulnar artery (a) and not the hook of the  
hamate (H). Note expansion of the TSZ and the radial displacement of the median nerve (dotted  
ellipse).   
  
  
Supplementary Video 2: Ultrasound-Guided Carpal Tunnel Release  
US in-plane view of the device with distal (DIST) to the left, of the microknife (open arrow)  
cutting the TCL (solid arrows) from a distal-to-proximal direction.  
  
Supplementary Video 3: Confirming Complete Ultrasound-Guided Carpal Tunnel Release  
Out of plane view of device (open arrow) with radial to the right of the image, with the  
protective balloons (curved arrows) deflated, showing the device superficial to the boundaries of  
the transected TCL (solid arrows).  
  
Page 20 of 25Journal of Ultrasound in Medicine














Figure 1.  Pre-procedural Anatomic Markings and Skin Incision  
Picture of incision placement along the distal forearm and device direction of insertion (arrow).    
Skin markings highlight the anatomic landmarks to assist during procedure.  Blue line represents place for 
incision.  Black dashed and solid red line marks location of the median nerve and ulnar artery respectively. 
a- superficial palmar arch; H- hook of hamate; P- pisiform, Mn- median nerve, U- ulnar nerve, S-scaphoid; 
T- Trapezium  
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Figure 2. Placement of Device and Balloon Inflation  
A) External intra3operative photo of device placement.  The device is initially inserted vertically until 
penetrating the antebrachial fascia, after which is advanced distally oblique-parallel to the forearm. B) In-
plane view of the device within the carpal tunnel with proximal (PROX) to the left of the image. The device is 
placed ~1 cm distal to the TCL (arrows) to ensure complete release. C) Out-of-plane view of the device 
(open arrow) within the transverse safe zone (dotted double arrow) at the level of the distal carpal tunnel 
(solid arrows). The protective balloons (curved arrows) are deflated as demonstrated in the insert.  The TSZ 
in this patient is bordered by the ulnar artery, which encroaches in the tunnel. Therefore, the ULN side of 
arrow spans from the median nerve (dotted ellipse) to the ulnar artery (a) and not the hook of the hamate 
(H). D)  
Out-of plane view of the device with protective balloons (curved arrows) inflated as  demonstrated in the 
insert. Note expansion of the TSZ (dotted double arrow) and the radial displacement of the median nerve 
(dotted ellipse). FT- flexor tendons;  
Solid ellipse - ulnar nerve; ThM- Thenar muscles; ULN- ulna  
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Figure 3.   Ultrasound-Guided Release of the Transverse Carpal Ligament  
A) External picture of the device with protective balloons inflated and the retrograde cutting knife (open 
arrow) deployed.  B) Correlative US in-plane view of the device with distal (DIST to the right of the knife 
(open arrow) cutting the TCL (solid arrows)  
 
33x22mm (300 x 300 DPI)  
 
 
Page 23 of 25 Journal of Ultrasound in Medicine














Figure 4.  Ultrasound Confirmation of Complete Release of the Transverse Carpal  Ligament  
Out of plane view of device (open arrow)  
, with the protective balloons (curved arrows) deflated, showing the device superficial to the boundaries of 
the transected TCL (solid arrows).    
a- ulnar artery; FCR- flexor carpi radialis - FT flexor tendons; Rad- radial; S- scaphoid; Solid ellipse - ulnar 
nerve; ThM- Thenar muscles; ULN- ulnar  
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Figure 5. Intraoperative photograph displaying closed incision with a single suture.  
 
41x87mm (300 x 300 DPI)  
 
 
Page 25 of 25 Journal of Ultrasound in Medicine
This article is protected by copyright. All rights reserved.
